Classification
- Anatomical main groupLAntineoplastic and immunomodulating agents
- Therapeutic subgroupL01Antineoplastic agents
- Pharmacological subgroupL01XOther antineoplastic agents
- Chemical subgroupL01XX
- Chemical substanceL01XX67Tagraxofusp
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Spain
AEMPS · 1 registration
European Union
EMA · 1 registration
Croatia
HALMED · 1 registration
Netherlands
CBG-MEB · 1 registration
At a glance
- ATC code
- L01XX67
- Registers
- 6
- Registrations
- 6
- With their own page
- 6
- Companies
- 4
All medicines with Tagraxofusp
Human medicines from every register that match Tagraxofusp by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
6 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Elzonris | United States | 1000MCG | solution | Marketed | Stemline Therapeutics INC |
| Elzonris | European Union | Authorised | Stemline Therapeutics B.V. | ||
| ELZONRIS 1 mg/ml, oplossing voor infusie | Netherlands | Oplossing voor infusie | Authorised | TMC Pharma (EU) Limited | |
| Elzonris 1 MG/ML Concentrado Para Solucion Para Perfusion | Spain | 1 mg/ml | concentrado para solución para perfusión | Authorised | Stemline Therapeutics B.V. |
| Elzonris Concentrate for Solution for Infusion 1000 MCG/ML | Singapore | 1.0 MG/mL | infusion, solution concentrate | Authorised | A. Menarini Singapore Pte. LTD. |
| Elzonris | Croatia | Authorised |